Neural Regen Res, 2013 · DOI: 10.3969/j.issn.1673-5374.2013.35.004 · Published: December 1, 2013
This study investigates the role of programmed cell death 1 ligand 1 (PD-L1) in experimental allergic encephalomyelitis (EAE), a mouse model for multiple sclerosis (MS). EAE mice showed inflammatory changes in the central nervous system, similar to those seen in MS. The expression of PD-L1 was found to be significantly increased in the spinal cord and splenocytes of mice with EAE compared to normal mice. These findings suggest that PD-L1 is involved in the pathogenesis of EAE and might be relevant to MS. The researchers used a novel method to immunize mice by injecting the antigen into the armpit, which contains abundant lymphoid tissue, facilitating antigen transport and immunological reactions. This single-point injection also helps to avoid tolerance to antigens and reduce morbidity.
PD-L1 might be a potential treatment target for multiple sclerosis.
Detecting PD-L1 expression in peripheral blood lymphocytes of patients with multiple sclerosis may assist the evaluation and prediction of disease progression, remission, relapse and the treatment efficacy of multiple sclerosis.
Blocking the inhibition of PD-L1/PD-1 signaling pathways on immune responses by autoimmune antibodies might be an underlying mechanism of autoimmune diseases.